HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 1.86
Day range
kr 1.80 - kr 1.93
Year range
kr 0.51 - kr 4.90
Market cap
82.06M SEK
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 604.00K | 16.15% |
Operating expense | 24.76M | -49.09% |
Net income | -2.95M | 94.30% |
Net profit margin | -487.75 | 95.09% |
Earnings per share | — | — |
EBITDA | 11.27M | 126.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 51.18M | -25.00% |
Total assets | 71.02M | -71.93% |
Total liabilities | 27.33M | -53.47% |
Total equity | 43.70M | — |
Shares outstanding | 45.29M | — |
Price to book | 1.94 | — |
Return on assets | -71.17% | — |
Return on capital | -93.09% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.95M | 94.30% |
Cash from operations | -24.42M | 38.49% |
Cash from investing | — | — |
Cash from financing | -1.54M | 1.98% |
Net change in cash | -25.61M | 32.26% |
Free cash flow | -18.73M | 18.07% |
About
Founded
2007
Website
Employees
11